Genetic multiple congenital anomalies/dysmorphic syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:183533
Who is this for?
Show terms as
1Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Genetic multiple congenital anomalies/dysmorphic syndrome (Orphanet code 183533) is a broad classification category used in rare disease nomenclature rather than a single specific disease entity. It encompasses a large and heterogeneous group of genetic conditions characterized by the presence of multiple congenital anomalies (birth defects affecting the structure or function of organs) combined with dysmorphic features (unusual physical characteristics involving the face, limbs, or other body structures). These syndromes are caused by underlying genetic alterations, which may include chromosomal abnormalities, single-gene mutations, or other genomic rearrangements. Patients within this category typically present at birth or early infancy with a combination of structural malformations affecting multiple organ systems, which may include the heart, brain, kidneys, skeleton, and gastrointestinal tract, along with distinctive facial features such as unusual eye spacing, ear shape, or jaw size. Intellectual disability and developmental delay are common but not universal features. The specific combination and severity of anomalies vary widely depending on the precise underlying genetic cause. Because this is a grouping category rather than a single disorder, there is no single treatment approach. Management is individualized and typically involves a multidisciplinary team including geneticists, cardiologists, neurologists, orthopedic surgeons, and developmental specialists. Treatment is largely supportive and symptomatic, addressing specific malformations through surgical correction when possible, developmental therapies, and ongoing monitoring. Genetic testing, including chromosomal microarray and exome or genome sequencing, plays a critical role in identifying the specific underlying diagnosis, which can guide prognosis and management.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Genetic multiple congenital anomalies/dysmorphic syndrome.

View clinical trials →

No actively recruiting trials found for Genetic multiple congenital anomalies/dysmorphic syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Genetic multiple congenital anomalies/dysmorphic syndrome community →

Specialists

1 foundView all specialists →
SF
Sofia Douzgou, MD PhD FRCP
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Genetic multiple congenital anomalies/dysmorphic syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Genetic multiple congenital anomalies/dysmorphic syndromeForum →

No community posts yet. Be the first to share your experience with Genetic multiple congenital anomalies/dysmorphic syndrome.

Start the conversation →

Latest news about Genetic multiple congenital anomalies/dysmorphic syndrome

1 articles
Clinical trialCLINICALTRIALSMar 26, 2026
Trial Now Recruiting: Genome Medical Sequencing for Gene Discovery (NCT01087320)
Researchers are recruiting 2,000 people with rare genetic disorders to participate in a study using a new technology called genome sequencing. This technology r
See all news about Genetic multiple congenital anomalies/dysmorphic syndrome

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Genetic multiple congenital anomalies/dysmorphic syndrome

What is Genetic multiple congenital anomalies/dysmorphic syndrome?

Genetic multiple congenital anomalies/dysmorphic syndrome (Orphanet code 183533) is a broad classification category used in rare disease nomenclature rather than a single specific disease entity. It encompasses a large and heterogeneous group of genetic conditions characterized by the presence of multiple congenital anomalies (birth defects affecting the structure or function of organs) combined with dysmorphic features (unusual physical characteristics involving the face, limbs, or other body structures). These syndromes are caused by underlying genetic alterations, which may include chromoso

At what age does Genetic multiple congenital anomalies/dysmorphic syndrome typically begin?

Typical onset of Genetic multiple congenital anomalies/dysmorphic syndrome is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Genetic multiple congenital anomalies/dysmorphic syndrome?

1 specialists and care centers treating Genetic multiple congenital anomalies/dysmorphic syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.